Patents by Inventor Paolo Grieco

Paolo Grieco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDIC AND NON PEPTIDIC LIGANDS FOR IMMUNODETECTION OF THE RECEPTOR FOR UROTENSIN II
    Publication number: 20150330983
    Abstract: The use of opportunely modified specific ligands of the receptor for urotensin II (UTR) or antibodies (commercially available) raised against the same receptor as tools for the definition of both the differentiation and the prognosis of human prostate adenocarcinoma is described, moreover, the use of opportunely radiolabeled ligands for UTR in the definition of the extension of disease is also described.
    Type: Application
    Filed: December 9, 2013
    Publication date: November 19, 2015
    Inventors: Ettore NOVELLINO, Paolo GRIECO, Michele CARAGLIA, Alfredo BUDILLON, Renato FRANCO, Santolo Rosaria ADDEO
  • Melanocortin analogs with antimicrobial activity
    Patent number: 8513381
    Abstract: The present invention finds application in the therapeutic fields. In particular, it concerns new synthetic melanocortin peptides having improved antimicrobial activity.
    Type: Grant
    Filed: January 19, 2009
    Date of Patent: August 20, 2013
    Assignee: Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico
    Inventors: Anna Catania, Ferruccio Bonino, Paolo Grieco, Ettore Novellino
  • MELANOCORTIN ANALOGS WITH ANTIMICROBIAL ACTIVITY
    Publication number: 20120015873
    Abstract: The present invention finds application in the therapeutic fields. In particular, it concerns new synthetic melanocortin peptides having improved antimicrobial activity.
    Type: Application
    Filed: January 19, 2009
    Publication date: January 19, 2012
    Inventors: Anna Catania, Ferruccio Bonino, Paolo Grieco, Ettore Novellino
  • PEPTIDIC AND NON PEPTIDIC LIGANDS FOR IMMUNODETECTION OF THE RECEPTOR FOR UROTENSIN
    Publication number: 20100099604
    Abstract: The use of opportunely modified specific ligands of the receptor for urotensin II (UTR) or antibodies (commercially available) raised against the same receptor as tools for the definition of both the differentiation and the prognosis of human prostate adenocarcinoma is described, moreover, the use of opportunely radiolabeled ligands for UTR in the definition of the extension of disease is also described.
    Type: Application
    Filed: February 8, 2008
    Publication date: April 22, 2010
    Inventors: Ettore Novellino, Paolo Grieco, Michele Caraglia, Alfredo Budillon, Renato Franco, Santolo Rosario Addeo